Clinical Trials Browser

Approved for marketing × Leukemia × Clear all

NCT03501615 2020-06-29

MOXE

Approved for marketing

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell

NCT00481559 2014-01-17

Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

Approved for marketing

LymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Neoplasms, Osteosarcoma, Renal Insufficiency